Royalty Pharma PLC

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Royalty Pharma PLC
TickerRPRX
CIK #0001802768
CUSIP76028H209
SectorLife Sciences - Pharmaceutical Preparations
Address110 East 59th Street, New York, NY 10022
Source [EDGAR]
CIK Filing 2011 - 2024
[0001802768] 10-K
[0001802768] 10-Q
[0001802768] 3
[0001802768] 4
[0001802768] 5
[0001802768] 8-K
[0001802768] SC 13D
[0001802768] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vanguard Group Inc Royalty Pharma PLC [2022-02-10] 6.9
General Atlantic LLC Royalty Pharma PLC [2021-02-16] 6.4
Morgan Stanley Royalty Pharma PLC [2021-02-09] 6.1
FMR LLC Royalty Pharma PLC [2021-02-08] 0.0
Giuliani Mario Germano Royalty Pharma PLC [2020-06-29] 3.4
Adage Capital Partners GP LLC Royalty Pharma PLC [2020-06-24] 12.58
Form 3/4/5 Filer 2011 - 2024
Legorreta Pablo G.
Royalty Pharma plc
Lloyd George W.
Riggs RORY B
Fernandez Henry A
Bassler Bonnie L
Urist Marshall
Avara Management Ltd
Skyeline Management Ltd
Giuliani Mario Germano
MGG Strategic SICAF SIF S.A.
MGG Strategic SICAF SIF S.A. - MGG Strategic
Coyne Terrance P.
Reddoch James F.
GG 1978 SICAF SIF S.A. - GG Strategic
GG 1978 Sicaf SIF Sa
Hodgson David C
Desouza Errol B
Love Ted W
Norden Gregory
Engelbert Catherine M.
Ford William E
Hite Christopher
Atchinson Robert
Gross Phillip
Adage Capital Advisors, L.L.C.
Adage Capital Partners, L.P.
Adage Capital Partners GP LLC
Severgnini Achille G.
Form 13F Holdings
Firm Period DFND Voting Shares
Morgan Stanley [2023-03-31] DFND 39,345,667.0 47,350,458.0
FMR LLC [2023-03-31] DFND 39,615,470.0 39,984,116.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 37,097,088.0
BlackRock Inc. [2023-03-31] SOLE 16,952,602.0 19,846,669.0
Viking Global Investors LP [2023-03-31] SOLE 11,204,249.0 11,204,249.0
Baillie Gifford & Co [2023-03-31] DFND 9,218,898.0 10,796,334.0
JPMorgan Chase & Co [2023-03-31] DFND 8,053,915.0 8,670,889.0
State Street Corp [2023-03-31] DFND 6,939,468.0 8,340,805.0
Baillie Gifford & Co [2023-03-31] SOLE 5,275,552.0 8,122,416.0
Adage Capital Partners GP LLC [2023-03-31] SOLE 7,244,867.0 7,244,867.0
Geode Capital Management LLC [2023-03-31] DFND 5,992,126.0 5,992,126.0
abrdn plc [2023-03-31] DFND 3,978,415.0 3,978,415.0
Capital International Investors [2023-03-31] DFND 3,831,349.0 3,831,349.0
Siguler Guff Advisers LLC [2023-03-31] SOLE 3,391,754.0 3,391,754.0
Suvretta Capital Management LLC [2023-03-31] SOLE 3,047,049.0 3,047,049.0
Manufacturers Life Insurance Company the [2023-03-31] DFND 2,778,660.0 2,778,660.0
Janus Henderson Group PLC [2023-03-31] DFND 0.0 2,563,995.0
Northern Trust Corp [2023-03-31] DFND 689,309.0 2,477,655.0
Goldman Sachs Group Inc [2023-03-31] DFND 1,939,278.0 2,261,709.0
Price T Rowe Associates Inc /MD/ [2023-03-31] SOLE 449,533.0 2,253,848.0
Legal & General Group Plc [2023-03-31] DFND 1,883,713.0 2,253,400.0
Millennium Management LLC [2023-03-31] SOLE 2,038,882.0 2,038,882.0
Arrowstreet Capital Limited Partnership [2023-03-31] DFND 1,953,497.0 1,956,125.0
Bank of America Corp /DE/ [2023-03-31] DFND 145,540.0 1,882,410.0
Bank of New York Mellon Corp [2023-03-31] DFND 1,092,362.0 1,650,297.0
Mitsubishi UFJ Trust & Banking Corp [2023-03-31] SOLE 1,586,984.0 1,586,984.0
General Atlantic LP [2023-03-31] SOLE 1,500,000.0 1,500,000.0
Ameriprise Financial Inc [2023-03-31] DFND 0.0 1,485,436.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 1,407,537.0 1,407,537.0
Swiss National Bank [2023-03-31] SOLE 1,400,400.0 1,400,400.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com